What are the first line treatments and home care advice for patients with psoriasis or eczema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment and Home Advice for Psoriasis and Eczema

Psoriasis First-Line Treatment

For mild psoriasis (<5% body surface area), start with combination therapy using a high-potency topical corticosteroid (class 2-5) plus vitamin D analog (calcipotriene) applied once daily for up to 4 weeks, as this provides superior efficacy compared to either agent alone. 1, 2

Topical Corticosteroid Selection by Location

  • Trunk and extremities: Use moderate-to-high potency corticosteroids (class 2-5) for maximum 4 weeks 2
  • Face, genitals, and skin folds: Use only low-potency corticosteroids or switch to tacrolimus 0.1% to avoid skin atrophy 1, 2
  • Scalp: Use clobetasol propionate 0.05% shampoo twice weekly, leaving on for 5-10 minutes before rinsing, for up to 4 weeks maximum 3
  • Thick plaques: Start with ultra-high potency (class 1) corticosteroids under dermatology supervision 4, 2

Critical Corticosteroid Safety Rules

  • Never exceed 100g of moderate-potency corticosteroid per month 4, 2
  • Require regular clinical review every 4 weeks during active treatment 4, 3
  • Never provide unsupervised repeat prescriptions 4, 2
  • Plan annual periods using alternative non-corticosteroid treatments to prevent tachyphylaxis 4, 2
  • Taper frequency gradually after improvement rather than abrupt cessation to prevent rebound flare 3

Alternative Topical Agents for Psoriasis

  • Coal tar: Start with 0.5-1.0% crude coal tar in petroleum jelly, increase every few days to maximum 10% if tolerated 4
  • Dithranol (anthralin): Begin at 0.1-0.25% concentration, double the concentration as tolerated, using "short contact mode" (15-45 minutes daily) to minimize irritation and staining 4
  • Vitamin D analogs alone: Use calcipotriene up to 100g per week maximum to avoid hypercalcemia 1
  • Tazarotene: Combine with moderate-to-high potency corticosteroids to reduce irritation 2

Maintenance Strategy for Psoriasis

After initial 4-week treatment achieves control, switch to weekend-only corticosteroid application while using vitamin D analogs on weekdays 2. For scalp psoriasis, transition to ketoconazole 2% shampoo once weekly after completing corticosteroid course 3.


Eczema (Atopic Dermatitis) First-Line Treatment

For atopic eczema, apply emollients liberally 1-3 times daily as the foundation of therapy, combined with mildly potent corticosteroids for children or moderately potent corticosteroids for adults during flares. 4, 3

Emollient Application Technique

  • Apply emollients in the direction of hair growth to reduce folliculitis risk 4
  • Use impermeable or semi-permeable films over emollients to enhance penetration 4
  • Continue emollients even when skin appears clear to maintain barrier function 3

Corticosteroid Selection for Eczema

  • Children: Use mildly potent corticosteroids as first-line 4
  • Adults: Use moderately potent corticosteroids as first-line 4
  • Sensitive areas (face, flexures, genitalia): Use low-potency corticosteroids or topical calcineurin inhibitors 4
  • Severe flares: May require brief course of potent corticosteroids under specialist supervision 4

Adjunctive Measures for Eczema

  • Sedating antihistamines at bedtime: Use large doses if needed to control nocturnal scratching; avoid daytime use 4
  • Wet wrap therapy: Apply emollients under damp bandages for severe flares 4
  • Avoid irritants: Identify and eliminate contact with soaps, detergents, and other triggers 5

Home Care Advice for Both Conditions

Medications That Worsen Psoriasis (Must Avoid)

  • Lithium, chloroquine, and mepacrine: Can cause severe, life-threatening psoriasis deterioration 4, 2
  • Beta-blockers and NSAIDs: May precipitate or worsen psoriasis in susceptible patients 4, 2
  • Systemic corticosteroids: Absolutely avoid as they cause severe rebound flares upon discontinuation 4, 2, 6
  • Alcohol: Known trigger for psoriasis exacerbations 4

Application Instructions

  • Apply topical treatments to damp skin immediately after bathing to enhance absorption 4
  • Use enough medication: Most patients under-apply topicals, reducing efficacy 4
  • Do not mix salicylic acid with calcipotriene: The acidic pH inactivates vitamin D analogs 2
  • Apply vitamin D analogs after phototherapy, not before: UV light inactivates these medications 1

When to Seek Specialist Referral

  • Diagnostic uncertainty 4
  • Failure to respond to first-line topical therapy after 4-6 weeks 4, 3
  • Body surface area >5% or involvement of vulnerable areas (face, hands, feet, genitals) 4
  • Symptoms causing significant pain, bleeding, or quality of life impairment 4
  • Signs of erythrodermic or pustular psoriasis 3
  • Need for second-line treatments (phototherapy, systemic agents) 4

Common Pitfalls to Avoid

The most common treatment failure is inadequate patient adherence due to poor understanding of application technique and unrealistic expectations about speed of response. 4, 2 Corticosteroids show improvement within 2 weeks, but vitamin D analogs require 6-8 weeks for full effect 7. Perceived "tachyphylaxis" to corticosteroids is usually poor adherence rather than true receptor down-regulation 2.

Long-term use of potent topical corticosteroids causes skin atrophy, striae, telangiectasia, and potential HPA axis suppression, particularly on the face and intertriginous areas 1, 6. Maximum treatment duration with high-potency agents is 4 weeks 3, 2.

Patients often fail to apply sufficient quantities of topical medications, leading to suboptimal outcomes 4. Reinforce proper application technique at every visit.

References

Guideline

Psoriasis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Psoriasis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Scalp Seborrheic Dermatitis and Psoriasis with Tenderness

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.